The corollary of labour-intensive, so economies of scale are less apparent for this is that policies and incentives to improve test-ordering are patient episode initiation.19 best directed at changing the behaviour of doctors – the agent of the patient – rather than the patients themselves.12 The pathology industry in Australia is characterised by a high degree of concentration and regulated price. [...] sum of 100 per cent of the fee for the most expensive procedure, plus 50 per cent of the fee for the second most expensive and 25 Fee-for-service has a number of strengths, including providing a per cent of the fee for all other procedures. [...] The negotiations would recognise the commercial realities of the industry and aim to ensure a good return for the The greatest savings opportunity is at the top of the list. [...] the impact.63 Listed company share prices declined precipitously with the announcement, suggesting the market shared that view.64 4.3 Cost to patients The chief executive of one of the affected companies, however, There are two main forms of cost to patients: out-of-pocket costs argued that consumers would bear the brunt of the change: incurred when a pathology test is not bulk-billed, and the tra. [...] Table 1 shows the results for the Because of the definition of pathology items and the coning rules, two clear categories of the schema.
- Pages
- 50
- Published in
- Australia
